Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V35588 | LHRH (1-6) amide | 37783-55-4 | LHRH (1-6) amide is a peptide compound. |
![]() |
V35589 | LHRH (3-10) | 38280-52-3 | LHRH (3-10) is a peptide compound. |
![]() |
V36547 | LL-37 | 597562-32-8 | LL-37 amide is a positively charged antimicrobial peptide. |
![]() |
V60003 | LQVTDSGLYRCVIYHPP TFA | LQVTDSGLYRCVIYHPP (LP17) TFA is a myeloid cell-expressed triggering receptor 1 (TREM-1) inhibitory peptide. | |
![]() |
V36553 | Luteinizing Hormone-Releasing Hormone Antagonist | Luteinizing Hormone-Releasing Hormone Antagonist is a peptide compound. | |
![]() |
V34928 | Lys-(Ala3)-Bradykinin | 103545-18-2 | Lys-(Ala3)-Bradykinin is a peptide compound. |
![]() |
V34929 | Lys-(Des-Arg9)-Bradykinin | 71800-36-7 | Lys-[Des-Arg9]Bradykinin is a naturally occurring kinin that is a potent and selective bradykinin B1 receptor agonist (activator) with Ki of B1 receptors in humans, mice and rabbits. |
![]() |
V34930 | Lys-(Des-Arg9,Leu8)-Bradykinin | 71800-37-8 | Lys-(Des-Arg9,Leu8)-Bradykinin is a bradykinin B1 receptor blocker (antagonist). |
![]() |
V34927 | Lys-Bradykinin | 342-10-9 | Lys-Bradykinin is Kinin and bradykinin receptor ligand generated by enzymatic cleavage of kininogen protein by the protease kallikrein. |
![]() |
V36522 | Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) | 172615-51-9 | IGF1Rtide can be used as a RET kinase substrate for RET kinase assays. |
![]() |
V35590 | Macrophage Inhibitory Peptide | 41961-56-2 | Macrophage Inhibitory Peptide is a peptide compound. |
![]() |
V36576 | MAGE-1 Antigen (161-169) (human) | 144449-86-5 | MAGE-1 Antigen (161-169) (human) is a peptide compound. |
![]() |
V36577 | MAGE-3 Antigen (167-176) (human) | 178243-46-4 | MAGE-3 Antigen (167-176) is a polypeptide containing 8 amino acid (AA)s. |
![]() |
V36578 | MAGE-3 Antigen (168-176) (human) | 154652-68-3 | MAGE-3 Antigen (168-176) (human) is a peptide compound. |
![]() |
V36579 | MAGE-3 Antigen (271-279) (human) | 160295-81-8 | MAGE-3 (271-279) is a short peptide with the sequence 271-279 of the melanoma antigen encoded by MAGE-3. |
![]() |
V85762 | MAP17 (Cell-penetrating peptide MAP17) | 1613241-14-7 | |
![]() |
V36929 | MAPKK2 (1-16) (human, mouse, rat) | MAPKK2 (1-16) (human, mouse, rat) is a peptide compound. | |
![]() |
V35591 | MARCKS Protein (151-175) | 134248-85-4 | MARCKS Protein (151-175) is a peptide compound. |
![]() |
V36556 | MART-1 (27-35) (human))|Melanoma-associated antigen peptide: MART-1(27-35),human | 156251-11-5 | MART-1 (27-35) (human) is an immunogenic epitope recognized by tumor-infiltrating lymphocytes (TIL) specific for HLA-A2-restricted melanoma. |
![]() |
V36557 | Mast Cell Degranulating (MCD) Peptide HR-1 | 80533-94-4 | HR1 is a papillary protease. |